DCBLD2 expression could be a useful diagnostic biomarker to evaluate invasive properties of myxofibrosarcoma (Kikuta et al., 2017), but its diagnostic value in PDAC remained unclear. The gene discussed is DCBLD2; the disease is myxofibrosarcoma.